Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis
Completed · Phase 3 · Has a placebo group
Conditions studied: Rheumatoid Arthritis
In brief
The primary purpose of the protocol is to demonstrate the ability of abatacept plus methotrexate to induce remission in patients with very early rheumatoid arthritis after 12 months of treatment and to maintain remission following 6 months of drug withdrawal.
Key facts
- Study ID
- NCT01142726
- Run by
- Bristol-Myers Squibb
- People needed
- 511
- Starts
- 2010-12-01
- Expected to finish
- 2014-10-01
- Last updated by the study team
- 2016-01-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- St. Joseph'S Mercy Clinic — Hot Springs, Arkansas, United States
- Sarasota Arthritis Research Center — Sarasota, Florida, United States
- Coeur D'Alene Arthrit Clin — Coeur d'Alene, Idaho, United States
- Johns Hopkins University Division Of Rheumatology — Baltimore, Maryland, United States
- Clinical Pharmacology Study Group — Worcester, Massachusetts, United States
- Arthritis Associates Of Mississippi — Jackson, Mississippi, United States
- Physician Research Collaboration, Llc — Lincoln, Nebraska, United States
- Piedmont Rheumatology, Pa — Hickory, North Carolina, United States
- Carolina Arthritis Associates — Wilmington, North Carolina, United States
- Metrohealth Medical Center — Cleveland, Ohio, United States
- Isam A. Diab, Md — Middleburg, Ohio, United States
- Alan J. Kivitz, Md, Cpi — Duncansville, Pennsylvania, United States
- Mitchell C. Feinman, Md — Orangeburg, South Carolina, United States
- Kurt Oelke, Md — Glendale, Wisconsin, United States
- Local Institution — Cairns, Queensland, Australia
- Local Institution — Maroochydore, Queensland, Australia
- Local Institution — Woodville, South Australia, Australia
- Local Institution — Heidelberg, Victoria, Australia
- Local Institution — Malvern, Victoria, Australia
- Local Institution — Victoria Park, Western Australia, Australia
- Local Institution — Brussels, Belgium
- Local Institution — Kortrijk, Belgium
- Local Institution — Merksem, Belgium
- Local Institution — Calgary, Alberta, Canada
- Rheumatology Associates Of North Alabama, P.C. — Huntsville, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.